Partner with the 13th Clinical Biomarkers & CDx Europe Summit to Meet With Key Precision Medicine Industry Decision-Makers
For over a decade, partnering with the 13th Clinical Biomarker & CDx Summit has been a proven way to attract the attention of precision medicine’s top decision-makers.
Facilitating end-to-end precision medicine progress, companies partner to create greater visibility of their expertise and trailblazing technologies. We are renowned by drug development decision-makers to initiate their important introductions with the most innovative CDx and assay developers to help them bring a unique CDx to European markets.
As the new IVDR framework takes off in Europe, we are facilitating closed-door conversations for senior decision makers and stakeholders of the industry to make deals and collaborations happen. This is your opportunity to stand out from the competition in front of a captive audience actively looking to meet their prospective partners in 2023 and beyond!
Who Should Partner?
Gathering large biopharma and exciting biotechs, working across a variety of modalities and disease indications – this summit brings you the diversity of participants to create wide-spread awareness and demand for your services.
Our Biomarkers & Diagnostics community highlighted the need for capabilities in:
Why Partner in 2023?
Benefit from Market Intelligence
Generate Commercial Collaborations
Position Yourself as an Industry Expert
Raise Brand Awareness
Meet & Network In-Person with Industry Pioneers